Deutsche Bank analyst Emmanuel Papadakis raised the firm’s price target on Sanofi to EUR 90 from EUR 85 and keeps a Hold rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNY:
- Sanofi price target raised to EUR 108 from EUR 102 at Guggenheim
- Sanofi announces withdrawal, refiling of premerger notice on Provention Bio deal
- Sanofi to Spin Off India Consumer Unit
- IGM Biosciences Sanofi sees FY23 revenue $3M, consensus $5.5M
- Regeneron price target raised to $650 from $605 at BofA